XSHG600141
Market cap3.27bUSD
Jan 06, Last price
21.68CNY
1D
1.40%
1Q
-8.41%
Jan 2017
70.98%
Name
HuBei XingFa Chemical Group Co Ltd
Chart & Performance
Profile
Hubei Xingfa Chemicals Group Co., Ltd. develops, produces, and sells phosphoric products and fine chemicals in Asia, Europe, the Americas, and Africa. It offers phosphoric products, such as dicalcium phosphate, phosphoric acid, sodium tripolyphosphate and hexametaphosphate, monosodium phosphate, trisodium phosphate and disodium phosphate food grade, sodium hypophosphite, sodium monofluorophosphate, tetrapotassium pyrophosphate, tetrasodium pyrophosphate, sodium trimetaphosphate, sodium acid pyrophosphate, trisodium acid pyrophosphate, monopotassium phosphate, dipotassium and tricalcium phosphate, tetrakis hydroxymethyl phosphonium sulfate, tetrakis hydroxymethyl phosphonium sulfate-urea, tetrakis hydroxymethyl phosphonium chloride, tetrakis hydroxymethyl phosphonium chloride-urea, triethylphosphate, TRIS(1-chloro-2-propyl) phosphate, and TRIS(hydroxymethyl) phosphine oxide. The company also provides compound food additives; herbicides; organosilicone; fertilizers; and electronic chemicals, including phosphoric and sulfuric acids EL grade, etchants, strippers, developers, and dimethyl sulfoxide. In addition, it offers basic chemicals comprising glycine, calcium and sodium hypochlorite, anhydrous calcium chloride, sodium hydroxide, phosphoric acid, phosphorus pentasulphide, yellow phosphorus, methylal, methyl chloride, phosphorus oxychloride, phosphorus trichloride, sodium hydroxide, calcium chloride dihydrate, liquid chlorine, hydrochloric and phosphorous acid, dimethyl sulfoxide, dimethyl sulfone, phosphate rocks, methyl disulfide, sodium methyl mercaptide, sodium fluorosilicate, ferrophosphorus, and dimethyl dichlorosilance. Hubei Xingfa Chemicals Group Co., Ltd. was founded in 1994 and is headquartered in Yichang, the People's Republic of China.
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|
2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | |
Income | |||||||||
Revenues | 28,105,346 -7.28% | 30,310,654 27.86% | |||||||
Cost of revenue | 25,365,384 | 21,231,840 | |||||||
Unusual Expense (Income) | |||||||||
NOPBT | 2,739,962 | 9,078,813 | |||||||
NOPBT Margin | 9.75% | 29.95% | |||||||
Operating Taxes | 328,963 | 1,074,174 | |||||||
Tax Rate | 12.01% | 11.83% | |||||||
NOPAT | 2,410,998 | 8,004,639 | |||||||
Net income | 1,378,918 -76.44% | 5,851,704 36.67% | |||||||
Dividends | (1,462,763) | (555,862) | |||||||
Dividend yield | 6.80% | 1.71% | |||||||
Proceeds from repurchase of equity | (200,049) | (3,692) | |||||||
BB yield | 0.93% | 0.01% | |||||||
Debt | |||||||||
Debt current | 3,093,240 | 3,529,990 | |||||||
Long-term debt | 9,142,954 | 8,020,774 | |||||||
Deferred revenue | 699,513 | 701,914 | |||||||
Other long-term liabilities | 413,804 | 509,905 | |||||||
Net debt | 8,080,516 | 4,696,692 | |||||||
Cash flow | |||||||||
Cash from operating activities | 1,453,446 | 6,883,530 | |||||||
CAPEX | (2,432,210) | ||||||||
Cash from investing activities | (2,616,229) | ||||||||
Cash from financing activities | (1,496,831) | ||||||||
FCF | (1,484,112) | 2,135,344 | |||||||
Balance | |||||||||
Cash | 2,320,433 | 4,791,290 | |||||||
Long term investments | 1,835,246 | 2,062,782 | |||||||
Excess cash | 2,750,411 | 5,338,539 | |||||||
Stockholders' equity | 13,645,609 | 14,622,596 | |||||||
Invested Capital | 32,574,820 | 27,874,783 | |||||||
ROIC | 7.98% | 31.45% | |||||||
ROCE | 7.63% | 26.98% | |||||||
EV | |||||||||
Common stock shares outstanding | 1,178,562 | 1,123,183 | |||||||
Price | 18.25 -37.07% | 29.00 -23.44% | |||||||
Market cap | 21,508,761 -33.97% | 32,572,307 -22.68% | |||||||
EV | 30,854,259 | 38,304,671 | |||||||
EBITDA | 4,782,205 | 10,756,329 | |||||||
EV/EBITDA | 6.45 | 3.56 | |||||||
Interest | 10,945 | 8,694 | |||||||
Interest/NOPBT | 0.40% | 0.10% |